Chris is a lifelong endurance athlete with a diverse academic and professional background. He has degrees and experience in neuroscience, clinical psychology, art, documentary photography, and journalism, and has decades of professional experience in the cycling and travel industries. Most recently, he founded Alter Exploration, which crafts challenging, transformative cycling journeys in some of the world’s most stunning destinations.
Chris was born and raised in southeastern Connecticut. He took up running in elementary school, and it quickly became his sole competitive outlet. Ultimately, he won multiple state championships in cross-country and track.
Chris attended Colgate University and graduated with degrees in neuroscience and art. He spent the next three years at the National Institute of Mental Health conducting research on patients with schizophrenia. After another year researching a stem cell treatment for Parkinson’s disease, he decided to pursue his second passion. This led him to the graduate journalism program at the University of Texas at Austin, where he concentrated in documentary photography. This is where Chris rediscovered his love of cycling, joining the collegiate team before expanding into categorized racing.
In 2012, Chris became the managing editor of VeloNews magazine, a position he held for nearly eight years. It was during that time that he became co-host of Fast Talk.
His cycling pursuits took him around the world to race on the road, mountain, and in cyclocross, to places like Taiwan, Costa Rica, Israel, and throughout Europe. He has stood on the podium at several cyclocross national championships, and is a silver medalist at master’s cyclocross worlds.
Chris is the author of The Haywire Heart, a groundbreaking and critically important guide to heart care for athletes, and the first book to delve into the relationship between long-term endurance athletics and heart health.
He is a cofounder of Fast Talk Labs, with Trevor Connor, and was the COO of Fast Talk Labs and The Paleo Diet until January 2022.